Methyl 2,5-difluorobenzoate

Catalog No. :
ACXTLC298
CAS No. :
362601-90-9
Molecular Formula :
C8H6F2O2
Molecular Weight :
172.13

IUPAC Name:methyl 2,5-difluorobenzoate

Methyl 2,5-difluorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$65.00Login to see priceIn stockInquiry
500g97%$320.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2,5-difluorobenzoate
IUPAC Namemethyl 2,5-difluorobenzoate
MDL No.MFCD03093800
Molecular FormulaC8H6F2O2
Molecular Weight172.13
SMILESCOC(=O)C1=C(F)C=CC(F)=C1
InChI KeyUDBLTZWJCWPYBA-UHFFFAOYSA-N
SynonymMethyl 2,5-difluorobenzoate | 362601-90-9 | 2,5-Difluorobenzoic acid methyl ester | methyl-2,5-difluorobenzoate | MFCD03093800 | Benzoic acid, 2,5-difluoro-, methyl ester | SCHEMBL112046 | AMY6569 | DTXSID10381413 | METHYL2,5-DIFLUOROBENZOATE | Methyl 2,5-difluorobenzoate, 9
CAS No.362601-90-9
PubChem CID2779364

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXTLC298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACFSKG167 route compound structure diagram
    ACFSKG167522651-42-9 In Stock
  4. Then
  5. ACXTLC298 route product structure diagram
    ACXTLC298362601-90-9 In Stock
Inquiry

2. ACXTLC298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACFSKG167 route compound structure diagram
    ACFSKG167522651-42-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXTLC298 route product structure diagram
    ACXTLC298362601-90-9 In Stock
Inquiry

Comments (0)